Pharmaceuticals

Personalized Medicine Market Insights Highlighting Opportunities Supporting Growth To 2030

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Personalized Medicine Market In 2026 And 2030?

The personalized medicine market size has observed rapid expansion in recent years. It is projected to expand from $422.9 billion in 2025 to $469.11 billion in 2026, registering a compound annual growth rate (CAGR) of 10.9%. The drivers behind its historical growth include the increasing prevalence of chronic diseases, breakthroughs in genetic sequencing, augmented healthcare expenditure, heightened awareness regarding personalized medicine, and the prompt integration of digital health solutions.

The personalized medicine market is projected to experience substantial expansion over the coming years. This market is anticipated to reach a valuation of $733.27 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.8%. Several factors will drive this growth throughout the forecast period, including the incorporation of AI into diagnostics and therapeutics, the proliferation of gene and cell therapy products, rising demand for remote patient monitoring, the creation of precision nutrition solutions, and the increasing uptake of companion diagnostics. Key trends expected during this period encompass personalized genetic profiling, the development of targeted drugs, patient-centric care frameworks, remote health monitoring, and preventive therapies based on lifestyle factors.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp

Which Important Drivers Are Guiding The Personalized Medicine Market Growth?

The expanding obese population is projected to fuel the growth of the personalized medicine market moving forward. Obesity is characterized by the unusual or excessive accumulation of body fat, which can detrimentally affect an individual’s health. Personalized medicine is utilized to target the specific genetic and molecular factors that contribute to obesity, thereby offering tailored and effective treatment approaches for individuals. For instance, in December 2024, data from the Office for Health Improvement and Disparities, a UK-based government department, indicated that the percentage of women living with obesity in early pregnancy was 25.4% from 2022 to 2023, showing a slight increase to 26.2% from 2023 to 2024. Consequently, the rising obese population is driving the expansion of the personalized medicine market.

How Is The Personalized Medicine Market Broken Down By Segment Categories?

The personalized medicine market covered in this report is segmented –

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness

2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications

3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users

Subsegments:

1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging

2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products

3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring

4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs

What Trends Are Transforming The Personalized Medicine Market?

Leading companies within the personalized medicine market are concentrating on developing technological advancements, such as artificial intelligence (AI)-powered platforms, to enhance diagnostic accuracy, customize treatments, and improve clinical trial efficiency. These AI-powered platforms utilize extensive data analysis to generate actionable insights into disease progression, patient reactions, and therapeutic outcomes. For instance, in April 2023, OM1, a US-based healthcare company leveraging real-world data and AI, patented an AI-powered platform aimed at accelerating personalized medicine. This platform provides tailored healthcare recommendations, supports informed decision-making for healthcare providers, and expedites clinical trials by efficiently identifying suitable patient candidates. By integrating AI-driven analytics into healthcare workflows, this technology advances personalized medicine and strengthens market growth.

Which Players Are Present In The Personalized Medicine Market Space?

Major companies operating in the personalized medicine market are Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.

Get The Full Personalized Medicine Market Report:

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

Where Is The Personalized Medicine Market Primarily Concentrated By Region?

North America was the largest region in the personalized medicine market in 2025. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Personalized Medicine Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

Browse Through More Reports Similar to the Global Personalized Medicine Market 2026, By The Business Research Company

Personalized Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

Genomics Personalized Health Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report

Personalized Nutrition Market Report 2026

https://www.thebusinessresearchcompany.com/report/personalized-nutrition-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795